Latest news
UBS Adjusts Jazz Pharmaceuticals Price Target to $315 From $307, Maintains Buy Rating - MoomooMoomoo · Wed, 05 Aug 2026 17:04:14 GMTJAZZ Maintains Overweight Rating by JP Morgan -- Price Target Ra - GuruFocusGuruFocus · Tue, 04 Aug 2026 20:59:03 GMTJAZZ Maintained by TD Cowen -- Price Target Raised to $300 - GuruFocusGuruFocus · Tue, 04 Aug 2026 18:56:25 GMTRobert W. Baird Boosts Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $280.00 - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:53:06 GMTRBC Capital Adjusts Price Target on Jazz Pharmaceuticals to $273 From $258, Maintains Outperform Rating - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 12:41:19 GMTJAZZ Maintains Outperform by Baird -- Price Target Raised to $28 - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:19:18 GMTJAZZ Maintains Overweight Rating -- Price Target Raised to $270 - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:09:01 GMTJAZZ Maintains Buy Rating -- Price Target Raised by Needham to $292 - GuruFocusGuruFocus · Tue, 04 Aug 2026 12:04:52 GMT